Idea principal
In two cross-sectional groups of adults with diabetes (3,418 from NHANES and 765 hospitalized Chinese patients), each unit higher HbA1c was associated with higher odds of existing cardiovascular disease (OR 1.097 and OR 1.413). Because both groups were measured at one point in time, the data cannot show whether high HbA1c came before the heart disease.
Study design
Estudio de cohorte
Reading basis
Published abstract
Reading focus
Association & confounding
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Heart and vascular disease is a major complication of diabetes, and different blood sugar measures capture different things. The authors compared fasting blood glucose (FBG), glycated hemoglobin A1c (HbA1c) and the triglyceride-glucose (TyG) index to see which relate best to cardiovascular disease already present in adults with diabetes.
Población y método
Two independent cross-sectional cohorts of adults with diabetes: a population-based cohort from the National Health and Nutrition Examination Survey (NHANES) 2005-2020 (n = 3,418) and a Chinese clinical cohort of hospitalized patients (n = 765). Multivariable logistic regression, subgroup analyses and restricted cubic spline analyses assessed the link between each biomarker and prevalent cardiovascular disease, with adjustment for potential confounders.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1HbA1c was consistently associated with prevalent cardiovascular disease in both cohorts after full adjustment.
- 2Each unit increase in HbA1c carried higher odds of cardiovascular disease in NHANES (OR 1.097, 95% CI 1.002-1.202, P = 0.045) and in the clinical cohort (OR 1.413, 95% CI 1.280-1.564, P < 0.001). The NHANES association is modest and borderline.
- 3FBG and TyG were not significantly associated with prevalent cardiovascular disease in the fully adjusted models.
- 4HbA1c showed no evidence of a nonlinear relationship in NHANES, but a significant nonlinear association in the clinical cohort; TyG showed a significant nonlinear association in NHANES.
- 5Subgroup analyses did not show consistent evidence that the link differed by demographic or clinical characteristics.
Límites e incertidumbre
- 1The cross-sectional design measures glucose and disease together, so the order of events and causation cannot be determined; the authors call for longitudinal studies.
- 2Cardiovascular disease was prevalent disease, which may have been identified differently in a national survey and in a hospital, and the two populations are not directly comparable.
- 3Hospitalized patients are sicker and more selected than the general population, which may explain the larger odds ratio in the clinical cohort.
- 4The abstract does not report diabetes duration or treatment details; this reading is based on the abstract only.
Relevancia práctica
HbA1c, which reflects average glucose over the past months, tracked more consistently with existing cardiovascular disease than a single fasting glucose or the TyG index. This does not prove that lowering HbA1c prevents heart disease. Targets and treatment for diabetes should be set with your clinician.
Tus datos
HbA1c is a lab test, though continuous glucose monitor users may see an estimated value in their app. Fasting glucose from a meter or CGM varies day to day, so look at trends across weeks and use the same device. Bring these trends to your regular diabetes review.
Cómo interpretar la evidencia
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Cardiovascular disease (CVD) remains a major complication contributing to morbidity and mortality among individuals with diabetes. Different glycemic biomarkers reflect distinct aspects of glucose metabolism, but their associations with prevalent CVD across different diabetic populations remain incompletely understood. This study aimed to evaluate the associations of fasting blood glucose (FBG), glycated hemoglobin A1c (HbA1c), and triglyceride-glucose index (TyG) with prevalent CVD among adults with diabetes.
Methods
This study included adults with diabetes from two independent cross-sectional cohorts: a population-based cohort derived from the National Health and Nutrition Examination Survey (NHANES) 2005-2020 (n = 3,418) and a Chinese clinical cohort of hospitalized patients with diabetes (n = 765). Multivariable logistic regression models, subgroup analyses, and restricted cubic spline (RCS) analyses were performed to evaluate the associations between glycemic biomarkers and prevalent CVD.
Results
After adjustment for potential confounders, HbA1c was consistently associated with prevalent CVD in both cohorts. In the fully adjusted model, each unit increase in HbA1c was associated with higher odds of prevalent CVD in the population-based cohort (OR = 1.097, 95% CI: 1.002-1.202, P = 0.045) and the clinical cohort (OR = 1.413, 95% CI: 1.280-1.564, P < 0.001). In contrast, FBG and TyG were not significantly associated with prevalent CVD in the fully adjusted models. RCS analyses showed a significant overall association between HbA1c and prevalent CVD without evidence of nonlinearity in the NHANES cohort, whereas a significant nonlinear association was observed in the clinical cohort. TyG also showed a significant nonlinear association with prevalent CVD in the NHANES cohort. Subgroup analyses did not show consistent evidence of effect modification across demographic and clinical characteristics.
Conclusion
Among adults with diabetes, HbA1c showed a consistent positive association with prevalent CVD across population-based and clinical cohorts, whereas the associations of FBG and TyG were less consistent. These findings support the relevance of HbA1c as a measure of long-term glycemic status in relation to prevalent CVD among individuals with diabetes. Further longitudinal studies are warranted to clarify the temporal relationship between HbA1c and cardiovascular outcomes.
Fuentes y atribución
Glycemic biomarkers and cardiovascular disease in diabetes: a comparative analysis of population-based and clinical cohorts.
Zhang L, Liu M, Zhang Y, Zhao L, Liu Y, Wang R, Zhou J, Li K.
Frontiers in endocrinology · 2026-10-14
DOI: 10.3389/fendo.2026.1995413 ↗PubMed · 42952496 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

